APA (7th ed.) Citation

Ho, I., Chiang, N., Lai, J., Chang, P. M., Chen, S., Hung, Y., & Chen, M. 5-Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan as a Potential Standard for Second-line Therapy in Extrapulmonary Neuroendocrine Carcinomas. Wolters Kluwer Medknow Publications.

Chicago Style (17th ed.) Citation

Ho, I-Wei, Nai-Jung Chiang, Jiun-I Lai, Peter Mu-Hsin Chang, San-Chi Chen, Yi-Ping Hung, and Ming-Huang Chen. 5-Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan as a Potential Standard for Second-line Therapy in Extrapulmonary Neuroendocrine Carcinomas. Wolters Kluwer Medknow Publications.

MLA (9th ed.) Citation

Ho, I-Wei, et al. 5-Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan as a Potential Standard for Second-line Therapy in Extrapulmonary Neuroendocrine Carcinomas. Wolters Kluwer Medknow Publications.